PC
Processa Pharmaceuticals, Inc.
PCSA · NASDAQ
$1.88 -1.57% (-$0.03)
1M -15.21%
Market Cap $5.09M
P/E Ratio -
Div. Yield -
ROE 394.24%
Bulios Fair Price
$2.41
28.2% upside
Trenutna cena
$1.88
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica PCSA trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
1/9Valuation
-
N/A P/E N/A
EV/EBITDA N/A
P/S N/A
Growth
0 /100
Declining Book val. growth 9.28%
EPS growth N/A
Rev. growth N/A
Profitability
-
N/A Gross margin N/A
Net margin N/A
Op. margin N/A
Quality
40 /100
Average ROIC 4,051.82%
ROE 394.24%
ROA 649.33%
Debt
12 /100
High Current ratio 0.87x
Int. coverage -6,708.03x
Debt/Equity N/A
Stability
74 /100
Stable Beta 0.97x
EPS volatility 17.57%
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o PCSA
Online
Sector
Healthcare
Industry
Biotechnology
CEO
George K. Ng
Employees
12
Headquarters
Vero Beach
Prihajajoči dogodki
29 OKT.
Earnings
Upcoming earnings report